Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Consumer Privacy Has Entered the Premium Tier Technology
  • Toyam Industries Ltd. launches a range of merchandise for ‘KUMITE 1 LEAGUE’ Business
  • Krishca Strapping Solutions Limited Reports Rs 150+ Crores in Total Revenue in FY25 Business
  • HYD7AM.com announces a writing competition for authors to celebrate Azadi Ka Amrit Mohatsav Business
  • UniPin Announces Retail Distribution Launch, Reaches More Gamers Across India Business
  • Director Aparana S Hosing releases the official trailer of the documentary film “Aastha Ek Vishwas.” Business
  • Bonanza Wealth Management Research gives a Buy Call on Radhika Jeweltech Ltd Business
  • Vivek Dholariya’s SkaiLand Entertainment enters Bengali feature films with Abhigyan Mukherjee’s Anumaner Bhittite Entertainment

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • Transforming Pregnancy Through the Power of Nurturing an Unborn Child’s Personality Within the Womb Health
  • Webinar Organised On World Patient Safety Day to Discuss ‘Safe Maternal & Newborn Care’ Health
  • Apollo Adlux Hospital Makes History with Hip Fracture Surgery on India’s Oldest Resident Health
  • SRV Hospitals and Lokmanya Hospital collaborate to launch a New Centre of Excellence in Robotic Orthopaedics Health
  • SUGARADHANA- A New Generation Sanitizer English
  • SEED, DocOnline, and CitiusTech Drive Digital Health Program in Slums of Bangalore, Hyderabad Health

Recent Posts

  • Lagnam Spintex Reports Strong Q2 & H1 Fy27 Performance; Ebitda Rises 98% In Q2 And 64% In H1fy27
  • PATHVIK Launches to End Career Guesswork: Students Can Now Experience a Career Before They Choose It
  • Celebrating 20 Years of Pioneering India’s Solar Revolution: Orb Energy’s Journey
  • As India’s Top Law Firms Embrace AI, VakilPlus Wants to Bring It to Every Lawyer
  • Onward Technologies Delivers its Strongest-Ever Quarter; Total Revenue up 22.2% and EBITDA up 33.7% YoY; Raises FY27 Outlook

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Arch College of Design and Business hosts Orientation and Freshers party to welcome new students Education
  • Saaj Bhatt’s “Tere Siva” Unveils a Musical Tale of Romance and Melody Entertainment
  • Robotic-Assisted Surgery with the Versius Robot Leads the Way for Patients All Over the World Technology
  • Dr. Aishwarya Paatapati Crowned Miss Globe India 2023 Lifestyle
  • JK WHITE CEMENT IN COLLABORATION WITH SINGER SHAAN, IS SPREADING HOPE THROUGH A MELODY – UMMEED! C
  • India-UK Free Trade Pact Signed | Transformative Gains on Global Scale National
  • Meet Srijita Mitra, taking the game of content creation to the next level A
  • Trom Industries Expands Order Pipeline with Municipal Infrastructure and Solar EPC Wins Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme